Skip to main content
. 2023 Aug 17;10(2):e002429. doi: 10.1136/openhrt-2023-002429

Table 2.

Association between baseline clinical characteristics, CMR findings and incidence of HFimpEF by logistic regression

Variables Beta SE HR 95% CI P value
Clinical
 Age −0.020 0.009 0.980 0.964 to 0.997 0.023
 Female 1.017 0.218 2.765 1.805 to 4.236 <0.001
 Baseline LVEF 0.044 0.014 1.045 1.017 to 1.074 0.002
 Diabetes mellitus −0.489 0.290 0.613 0.348 to 1.082 0.091
 HbA1c −0.025 0.010 0.975 0.955 to 0.995 0.017
 Hypertension −0.111 0.211 0.895 0.593 to 1.353 0.600
 Hypercholesterolaemia 0.022 0.233 1.022 0.648 to 1.614 0.924
 Cerebrovascular event −0.281 0.326 0.755 0.399 to 1.430 0.389
 Atrial fibrillation −0.397 0.223 0.672 0.434 to 1.041 0.075
 Current smoker −0.447 0.291 0.639 0.362 to 1.130 0.124
 Townsend Deprivation Index 0.055 0.029 1.057 0.998 to 1.120 0.061
 QRISK3 −0.024 0.008 0.977 0.962 to 0.992 0.003
 Time between echocardiography and CMR 0.002 0.001 1.002 1.000 to 1.004 0.029
Tissue characteristic
 Ischaemic LGE −1.459 0.357 0.233 0.115 to 0.468 <0.001
 Number of segments of ischaemic LGE −0.064 0.126 0.938 0.732 to 1.200 0.610
 Inducible ischaemia −0.946 0.560 0.388 0.129 to 1.165 0.091
 Number of segments of inducible ischaemia −0.142 0.222 0.867 0.562 to 1.339 0.520
 Non-ischaemic LGE −0.535 0.237 0.586 0.368 to 0.932 0.024
 Number of segments of non-ischaemic LGE −0.205 0.134 0.815 0.626 to 1.060 0.127

P-values set in bold indicate statistical significance.

CMR, cardiac magnetic resonance; HbA1c, glycated haemoglobin; HFimpEF, heart failure with improved ejection fraction; LGE, late gadolinium enhancement; LVEF, left ventricular ejection fraction.